Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This RNA is a long non-coding transcript antisense to the COL4A2 gene, meaning it is located on the DNA strand opposite the COL4A2 coding sequence and does not itself encode a protein. Its function is unknown, but being antisense to COL4A2 suggests a possible regulatory effect on COL4A2 expression. COL4A2 encodes a subunit of type IV collagen, which is crucial for basement membrane structure and implicated in several diseases, including cancer and fibrotic disorders[1][3]. No evidence supports this transcript as a protein-coding or druggable entity; its role, if any, remains speculative and uncharacterized in the scientific literature. This transcript is distinct from COL4A2, which is well-established as both structurally and pathologically important[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to COL4A2 (ENSG00000296215).